Reginster JY, Seeman E, DE Vernejoul MC, et al. Strontium ranelate reduces the risk of invertebral fractures in postmenopausal women with osteoporosis: Treatment of Perpheral Osteoporosis (TROPOS) study.
J Clin Endocrinol Metab. 2005 Feb 22 [Epub ahead of print].
Reginster JY, Meunier PJ. Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies.
Osteoporos Int. 2003. [Epub ahead of print].
Reginster JY, Deroisy R, Jupsin I. Strontium ranelate: a new paradigm in the treatment of osteoporosis.
DrugsToday (Barc). 2003;39:89–101.
Reginster JY, Deroisy R, Dougados M, Jupsin I, Colette J, Roux C. Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trial.
Osteoporos Int. 2002;13:925–31.
Meunier PJ, Slosman DO, Delmas PD, et al. Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis—a 2-year randomized placebo controlled trial.
J Clin Endocrinol Metab. 2002;87:2060–6.
Meunier PJ, Roux C, Seeman E, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.
N Engl J Med. 2004;350:459–68.
Brandi ML. New treatment strategies: ipriflavone, strontium, vitamin D metabolites and analogs.
Am J Med. 1993;95:69S–74S.
Matsumoto A. Effect of strontium chloride on bone resorption induced by prostaglandin E2 in cultured bone.
ArchToxicol. 1988;62:240–1.
Marie PJ, Hott M. Short-term effects of fluoride and strontium on bone formation and resorption in the mouse.
Metabolism. 1986;35:547–51.
Marie PJ, Garba MT, Hott M, Miravet L. Effect of low doses of stable strontium on bone metabolism in rats.
Miner Electrolyte Metab. 1985;11:5–13.
Brandi ML. New treatment strategies: ipriflavone, strontium, vitamin D metabolites and analogs.
Am J Med. 1993;95:69S–74S
Ferraro EF, Carr R, Zimmerman K. A comparison of the effects of strontium chloride and calcium chloride on alveolar bone.
Calcif Tissue Int. 1983;35:258–60.
Ferraro EF, Glass RT. The effect of strontium chloride upon alveolar bone.
J Periodontol. 1980;51:345–7.
Marie PJ. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
Curr Opin Rheumatol.
2006;18 Suppl 1:S11-5.
O'donnell S, Cranney A, Wells G, et al. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
Cochrane Database Syst Rev.
2006;:CD005326.
Halil M, Cankurtaran M, Yavuz BB, et al. Short-Term Hemostatic Safety of
Strontium Ranelate Treatment in Elderly Women with Osteoporosis. Ann
Pharmacother. 2007;41:41-5.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.